FinTrust Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.69K | Hold |
|
|||||
|
2024
Q2 | $2.02K | Hold |
|
|||||
|
2024
Q1 | $2.02K | Hold |
|
|||||
|
2023
Q4 | $1.93K | Sell |
|
|||||
|
2023
Q3 | $227K | Buy |
|
|||||
|
2023
Q2 | $141K | Sell |
|
|||||
|
2023
Q1 | $253K | Hold |
|
|||||
|
2022
Q4 | $299K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $11K | Hold |
|
|||||
|
2021
Q1 | $11K | Sell |
|
|||||
|
2020
Q4 | $15K | Sell |
|
|||||
|
2020
Q3 | $19 | Sell |
|
|||||
|
2020
Q2 | $53K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $0 | Hold |
|
|||||
|
2018
Q4 | $0 | Buy |
|